605 related articles for article (PubMed ID: 22426967)
1. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
2. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
3. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
4. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
5. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
6. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
8. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of second other-site primary cancers among sporadic colorectal cancer patients--a hospital-based study of 3,722 cases.
Chiang JM; Yeh CY; Changehien CR; Chen JS; Tang R; Tsai WS; Fan CW
Hepatogastroenterology; 2004; 51(59):1341-4. PubMed ID: 15362748
[TBL] [Abstract][Full Text] [Related]
10. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
11. Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer.
Liu L; Lemmens VE; De Hingh IH; de Vries E; Roukema JA; van Leerdam ME; Coebergh JW; Soerjomataram I
Dis Colon Rectum; 2013 Feb; 56(2):158-68. PubMed ID: 23303143
[TBL] [Abstract][Full Text] [Related]
12. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
13. [Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms].
Kövér E; Faluhelyi Z; Bogner B; Kalmár K; Horváth G; Tornóczky T
Magy Onkol; 2004; 48(4):315-21. PubMed ID: 15655577
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
Kamp K; Damhuis RA; Feelders RA; de Herder WW
Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
[TBL] [Abstract][Full Text] [Related]
15. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma.
Fante R; Roncucci L; Di GregorioC ; Tamassia MG; Losi L; Benatti P; Pedroni M; Percesepe A; De Pietri S; Ponz de Leon M
Cancer; 1996 May; 77(10):2013-21. PubMed ID: 8640664
[TBL] [Abstract][Full Text] [Related]
16. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
[TBL] [Abstract][Full Text] [Related]
18. Surveillance and monitoring of adult cancer survivors.
Choi M; Craft B; Geraci SA
Am J Med; 2011 Jul; 124(7):598-601. PubMed ID: 21683826
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
20. [What is the incidence of synchronous second cancers of the large intestine and of metachronous second cancers of the large intestine?].
Hahn EG; Nusko G
Internist (Berl); 1995 Dec; 36(12):1204-5. PubMed ID: 8567230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
